George P M, Conaghan C, Angus H B, Walmsley T A, Chapman B A
Department of Clinical Biochemistry, Christchurch Hospital, New Zealand.
J Clin Pathol. 1996 Feb;49(2):159-63. doi: 10.1136/jcp.49.2.159.
To compare a histological hepatic iron index with a biochemical hepatic iron index, derived from atomic absorption spectroscopy measurements of hepatic iron content, for the diagnosis of genetic haemochromatosis (GH).
Histological sections of liver biopsy specimens from 70 subjects, who had previously had their biochemical hepatic iron index measured, were examined. The iron stores were scored to derive a histological hepatic iron index and were also graded from 0 to 4 by a standard grading system. The case history of each patient was then reviewed to establish a definitive clinical diagnosis and patients were classified as GH, non-GH or indeterminate.
There were 26 cases of GH, 40 cases of non-GH and four indeterminate cases in whom a definite clinical diagnosis was not established. Using a biochemical hepatic iron index cut off level of 2.0, two cases were misclassified, with one case of GH having a biochemical hepatic iron index of 1.8 and one non-GH case having a biochemical hepatic iron index of 3.1. This could not have been improved by altering the cut off level. Using the recommended cut off level of 0.15, the histological hepatic iron index was raised in all cases of GH, but was also increased in 11 of the 40 non-GH patients. The specificity of this histological index can be improved by increasing the cut off level to 0.30. A histological iron grade of > or = 3 is more specific than the histological index but has a lower sensitivity, which particularly affects the diagnosis of younger patients with GH.
The biochemical hepatic iron index is a reliable method for establishing a diagnosis of homozygous GH. In contrast, the histological hepatic iron index as originally described is non-specific and does not reliably distinguish patients with GH from others with a raised hepatic iron index due to other causes. The specificity of this index can be improved by increasing the cut off level used, but the discrimination provided by the histological index is still inferior to that provided by the biochemical hepatic iron index.
比较组织学肝脏铁指数与生化肝脏铁指数(通过原子吸收光谱法测量肝脏铁含量得出)在遗传性血色素沉着症(GH)诊断中的应用。
对70名此前已测量生化肝脏铁指数的受试者的肝脏活检标本组织切片进行检查。对铁储存进行评分以得出组织学肝脏铁指数,并按照标准分级系统从0到4进行分级。然后回顾每位患者的病历以确立明确的临床诊断,患者被分为GH、非GH或不确定类别。
有26例GH病例、40例非GH病例以及4例无法确立明确临床诊断的不确定病例。使用生化肝脏铁指数截断值2.0时,有2例被错误分类,1例GH患者的生化肝脏铁指数为1.8,1例非GH患者的生化肝脏铁指数为3.1。改变截断值并不能改善这种情况。使用推荐的截断值0.15时,所有GH病例的组织学肝脏铁指数均升高,但40例非GH患者中有11例也升高。将该组织学指数的截断值提高到0.30可提高其特异性。组织学铁分级≥3比组织学指数更具特异性,但敏感性较低,这尤其影响年轻GH患者的诊断。
生化肝脏铁指数是确立纯合子GH诊断的可靠方法。相比之下,最初描述的组织学肝脏铁指数不具有特异性,无法可靠地区分GH患者与因其他原因导致肝脏铁指数升高的其他患者。通过提高所使用的截断值可提高该指数的特异性,但组织学指数提供的鉴别能力仍不如生化肝脏铁指数。